AACR Q&A: Elaine Mardis

The genomics pioneer shares the sessions she most looks forward to at this year’s American Association for Cancer Research annual meeting.

By | April 18, 2016

COURTESY OF ELAINE MARDIS

The American Association for Cancer Research (AACR) annual meeting is huge—so big that it can be tough to choose which talks to attend in person (or tune in to from afar). The Scientist asked Washington University in St. Louis’s Elaine Mardis—who is on the planning committee for this year’s conference, being held in New Orleans—to share her picks of the most buzzworthy topics in cancer research today.

The Scientist: To your mind, what are some of the hottest areas of cancer research right now?

Elaine Mardis: Immunotherapy and immunogenomics, liquid biopsy-based monitoring of patient response to therapy, [and] clinical genomic assays to identify therapeutic targets.

TS:  What are you presenting at AACR this year?  

EM: I am speaking in the opening plenary about cancer genomics and its transition to aid patient care in the cancer clinic. I also am providing a wrap-up of the cancer prevention and early detection work [being] presented at the meeting this year.                

TS: What new topics are emerging that have received less attention in past conferences?

EM: Liquid biopsy and early detection of cancers. Germline contribution of cancer susceptibility mutations in patients without a family history of cancer.

TS: What talks or posters do you anticipate finding most exciting?

EM: I think the Wednesday plenary lectures on single-cell genomics and the tumor heterogeneity plenary on Tuesday will have the most exciting talks.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech